AG
VIR icon

Algert Global’s Vir Biotechnology VIR Stock Holding History

Algert Global’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.38M Buy
+489,008
New +$3.9M 0.07% 477
2025
Q3 		– Sell
-19,802
Closed -$100K – 1355
2025
Q2 		$100K Hold
19,802
– – ﹤0.01% 1140
2025
Q1 		$128K Hold
19,802
– – ﹤0.01% 1117
2024
Q4 		$145K Sell
19,802
-193,663
-91% -$1.53M ﹤0.01% 1097
2024
Q3 		$1.6M Buy
213,465
+46,630
+28% +$405K 0.04% 631
2024
Q2 		$1.49M Buy
+166,835
New +$1.6M 0.05% 560
2024
Q1 		– Sell
-31,960
Closed -$322K – 1285
2023
Q4 		$322K Sell
31,960
-417,725
-93% -$3.82M 0.01% 923
2023
Q3 		$4.21M Buy
+449,685
New +$6.41M 0.2% 156
2023
Q1 		– Sell
-16,510
Closed -$418K – 1323
2022
Q4 		$418K Buy
+16,510
New +$405K 0.02% 863
2022
Q2 		– Sell
-19,465
Closed -$501K – 1397
2022
Q1 		$501K Buy
19,465
+12,346
+173% +$366K 0.03% 813
2021
Q4 		$298K Sell
7,119
-1,050
-13% -$41.1K 0.04% 732
2021
Q3 		$356K Buy
+8,169
New +$354K 0.05% 686

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Algert Global's VIR Position: Q1 2026 in Review

Algert Global opened a new position in Vir Biotechnology (VIR) in Q1 2026: 489,008 shares worth $4.38M. The stake represents 0.07% of the portfolio and ranks #477 among its holdings. This is a return to the name: Algert Global previously reported a position in VIR as recently as Q2 2025.

Algert Global first reported a position in VIR in Q3 2021 and has held it in 12 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Algert Global held 489,008 shares of Vir Biotechnology worth $4.38M as of Q1 2026.
  • Vir Biotechnology was a new Algert Global position in Q1 2026.
  • Vir Biotechnology made up 0.07% of Algert Global's portfolio in Q1 2026, its #477 holding.
  • Algert Global first reported a position in Vir Biotechnology in Q3 2021 and has held it in 12 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.